Cargando…

Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden

INTRODUCTION: The rapid rise in trade and use of NPS and the lack of information concerning their potential toxicity pose serious challenges to public health authorities across the world. Policy measures towards NPS taken so far have a special focus on their legal status, while the implementation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Neicun, Jessica, Steenhuizen, Marthe, van Kessel, Robin, Yang, Justin C., Negri, Attilio, Czabanowska, Katarzyna, Corazza, Ornella, Roman-Urrestarazu, Andres
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594604/
https://www.ncbi.nlm.nih.gov/pubmed/31242225
http://dx.doi.org/10.1371/journal.pone.0218011
_version_ 1783430262385803264
author Neicun, Jessica
Steenhuizen, Marthe
van Kessel, Robin
Yang, Justin C.
Negri, Attilio
Czabanowska, Katarzyna
Corazza, Ornella
Roman-Urrestarazu, Andres
author_facet Neicun, Jessica
Steenhuizen, Marthe
van Kessel, Robin
Yang, Justin C.
Negri, Attilio
Czabanowska, Katarzyna
Corazza, Ornella
Roman-Urrestarazu, Andres
author_sort Neicun, Jessica
collection PubMed
description INTRODUCTION: The rapid rise in trade and use of NPS and the lack of information concerning their potential toxicity pose serious challenges to public health authorities across the world. Policy measures towards NPS taken so far have a special focus on their legal status, while the implementation of a public health strategy seems to be still missing. The aim of this study is to perform a general assessment of NPS-related policy (including regulatory measures and public health strategies) implemented by six European countries: Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden. METHODS: Six EU countries were included in this scoping review study. Drug policies (including legal responses and public health strategies) were analysed. UNODC drug policy classification system was used as a benchmark, while path dependency approach was used for data analysis; a net of inter-dependencies between international, EU and national policies was highlighted. RESULTS AND DISCUSSION: The countries included in this study can be placed in a wide spectrum according to their formulation of drug policy, from Portugal and the UK that have specific legal responses to NPS but have differently focused on harm reduction strategies at one end, to Sweden whose drug-free society goal is not translated into a specific regulation of NPS at the other end. CONCLUSION: The findings of the study reveal limited development towards harmonisation of national drug policies–particularly with regard to NPS. To tackle the challenge presented by NPS, EU Member states have formulated legislation and public health strategies independently. National approaches to NPS are therefore in line with their already existing drug policies, reflecting cultural values towards substance abuse and national political interests, while the homogenization at an international level has so far mostly been focused on law enforcement and drugs use preventive strategies.
format Online
Article
Text
id pubmed-6594604
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65946042019-07-05 Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden Neicun, Jessica Steenhuizen, Marthe van Kessel, Robin Yang, Justin C. Negri, Attilio Czabanowska, Katarzyna Corazza, Ornella Roman-Urrestarazu, Andres PLoS One Research Article INTRODUCTION: The rapid rise in trade and use of NPS and the lack of information concerning their potential toxicity pose serious challenges to public health authorities across the world. Policy measures towards NPS taken so far have a special focus on their legal status, while the implementation of a public health strategy seems to be still missing. The aim of this study is to perform a general assessment of NPS-related policy (including regulatory measures and public health strategies) implemented by six European countries: Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden. METHODS: Six EU countries were included in this scoping review study. Drug policies (including legal responses and public health strategies) were analysed. UNODC drug policy classification system was used as a benchmark, while path dependency approach was used for data analysis; a net of inter-dependencies between international, EU and national policies was highlighted. RESULTS AND DISCUSSION: The countries included in this study can be placed in a wide spectrum according to their formulation of drug policy, from Portugal and the UK that have specific legal responses to NPS but have differently focused on harm reduction strategies at one end, to Sweden whose drug-free society goal is not translated into a specific regulation of NPS at the other end. CONCLUSION: The findings of the study reveal limited development towards harmonisation of national drug policies–particularly with regard to NPS. To tackle the challenge presented by NPS, EU Member states have formulated legislation and public health strategies independently. National approaches to NPS are therefore in line with their already existing drug policies, reflecting cultural values towards substance abuse and national political interests, while the homogenization at an international level has so far mostly been focused on law enforcement and drugs use preventive strategies. Public Library of Science 2019-06-26 /pmc/articles/PMC6594604/ /pubmed/31242225 http://dx.doi.org/10.1371/journal.pone.0218011 Text en © 2019 Neicun et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Neicun, Jessica
Steenhuizen, Marthe
van Kessel, Robin
Yang, Justin C.
Negri, Attilio
Czabanowska, Katarzyna
Corazza, Ornella
Roman-Urrestarazu, Andres
Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden
title Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden
title_full Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden
title_fullStr Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden
title_full_unstemmed Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden
title_short Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden
title_sort mapping novel psychoactive substances policy in the eu: the case of portugal, the netherlands, czech republic, poland, the united kingdom and sweden
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594604/
https://www.ncbi.nlm.nih.gov/pubmed/31242225
http://dx.doi.org/10.1371/journal.pone.0218011
work_keys_str_mv AT neicunjessica mappingnovelpsychoactivesubstancespolicyintheeuthecaseofportugalthenetherlandsczechrepublicpolandtheunitedkingdomandsweden
AT steenhuizenmarthe mappingnovelpsychoactivesubstancespolicyintheeuthecaseofportugalthenetherlandsczechrepublicpolandtheunitedkingdomandsweden
AT vankesselrobin mappingnovelpsychoactivesubstancespolicyintheeuthecaseofportugalthenetherlandsczechrepublicpolandtheunitedkingdomandsweden
AT yangjustinc mappingnovelpsychoactivesubstancespolicyintheeuthecaseofportugalthenetherlandsczechrepublicpolandtheunitedkingdomandsweden
AT negriattilio mappingnovelpsychoactivesubstancespolicyintheeuthecaseofportugalthenetherlandsczechrepublicpolandtheunitedkingdomandsweden
AT czabanowskakatarzyna mappingnovelpsychoactivesubstancespolicyintheeuthecaseofportugalthenetherlandsczechrepublicpolandtheunitedkingdomandsweden
AT corazzaornella mappingnovelpsychoactivesubstancespolicyintheeuthecaseofportugalthenetherlandsczechrepublicpolandtheunitedkingdomandsweden
AT romanurrestarazuandres mappingnovelpsychoactivesubstancespolicyintheeuthecaseofportugalthenetherlandsczechrepublicpolandtheunitedkingdomandsweden